Patents Assigned to Locus Genex Oy
  • Method for screening the risk of gastric cancer
    Publication number: 20010039025
    Abstract: Method for screening the risk for gastric cancer using, in combination, the determination of serum pepsinogen I, gastrin-17 and the supporting determination of Helicobacter pylori antibodies from blood serum, in order to detect either atrophy of the corpus area, atrophy of the antrum area or atrophy of the mucosa of the whole stomach as well as a causative Helicobacter pylori infection, whereby the risk for gastric cancer can be evaluated and the necessary gastroscopy and follow-up can be planned.
    Type: Application
    Filed: March 14, 2001
    Publication date: November 8, 2001
    Applicant: LOCUS GENEX OY
    Inventor: Matti Harkonen
  • Method for the detection of reactive conditions
    Patent number: 5420012
    Abstract: The invention relates to diagnosis of reactive conditions, such as malignant tumors. According to the invention, the amount of cellular fibronectin in a body fluid is determined, and an elevated amount is used as a marker for a reactive condition. The method is especially suitable for the diagnosis of carcinomas, such as colon carcinoma.
    Type: Grant
    Filed: October 23, 1992
    Date of Patent: May 30, 1995
    Assignee: Locus Genex Oy
    Inventors: Paul Partanen, Sari Ylatupa, Raili Paasivuo, Ismo Virtanen